.. Et-l-'ubinucléine-in-vivo, 60 A. Etude de l'interaction Ubn-14-3-3?, pp.14-17

A. Agarwal-mawal, H. Qureshi, P. Cafferty, Z. Yuan, D. Han et al., 14-3-3 connects Glycogen Synthase Kinase-3? to Tau within a brain microtubule-associated Tau phosphorylation complex, J Biol Chem, issue.15, pp.27812722-12728, 2003.

C. Aguilera, V. Fernandez-majada, J. Ingles-esteve, V. Rodilla, A. Bigas et al., Efficient nuclear export of p65-IB complexes requires 14-3-3 proteins, J Cell Sci, issue.17, pp.1193695-704, 2006.

S. Aho, M. Buisson, and T. Pajunen, Ubinuclein, a Novel Nuclear Protein Interacting with Cellular and Viral Transcription Factors, The Journal of Cell Biology, vol.14, issue.6, pp.1165-1176, 2000.
DOI : 10.1146/annurev.biochem.67.1.545

S. Aho, J. Lupo, and P. A. Coly, Characterization of the ubinuclein protein as a new member of the nuclear and adhesion complex components (NACos), Biology of the Cell, vol.118, issue.6, pp.319-334, 2009.
DOI : 10.1042/BC20080072

H. Aoki, Y. Arakawa, J. Hayashi, M. Moriyama, and O. Hino, Hepatitis C Virus Core Protein Interacts with 14-3-3 Protein and Activates the Kinase Raf-1, Journal of Virology, vol.74, issue.4, pp.1736-1741, 2000.
DOI : 10.1128/JVI.74.4.1736-1741.2000

H. Arbach and I. Joab, EBV and breast cancer: questions and implications, Epstein Barr Virus, pp.139-156, 2005.

S. Balaji, M. Lakshminarayan, L. Iyer, and . Aravind, HPC2 and ubinuclein define a novel family of histone chaperones conserved throughout eukaryotes, Molecular BioSystems, vol.31, issue.3, pp.269-275, 2009.
DOI : 10.1039/b816424j

A. Banerjee, K. Meyer, B. Mazumdar, R. Ray, and R. Ray, Hepatitis C Virus Differentially Modulates Activation of Forkhead Transcription Factors and Insulin-Induced Metabolic Gene Expression, Journal of Virology, vol.84, issue.12, pp.5936-5982, 2010.
DOI : 10.1128/JVI.02344-09

G. Banumathy, N. Somaiah, and R. Zhang, Human UBN1 Is an Ortholog of Yeast Hpc2p and Has an Essential Role in the HIRA, ASF1a Chromatin-Remodeling Pathway in Senescent Cells Mol Cell Biol, issue.3, pp.29758-770, 2009.

D. Berg, C. Holzmann, and O. Riess, 14-3-3 proteins in the nervous system, Nature Reviews Neuroscience, vol.4, issue.9, pp.752-762, 2003.
DOI : 10.1038/nrn1197

P. Bhende, W. Seaman, H. Delecluse, and S. Kenney, The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome, Nature Genetics, vol.73, issue.10, pp.361099-104, 2004.
DOI : 10.1128/MCB.23.8.2633-2644.2003

C. M. Borza and L. M. Hutt-fletcher, Alternate replication in B cells and epithelial cells switches tropism of Epstein???Barr virus, Nature Medicine, vol.8, issue.6, pp.594-599, 2002.
DOI : 10.1038/nm0602-594

A. Brunet, F. Kanai, and J. Stehn, 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport, The Journal of Cell Biology, vol.19, issue.5, pp.817-828, 2002.
DOI : 10.1074/jbc.272.21.13717

C. Chen, D. Li, and N. Guo, Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: Implications for therapy of EBV associated tumors, Cancer Biology & Therapy, vol.8, issue.11, pp.987-995, 2009.
DOI : 10.4161/cbt.8.11.8369

H. Chen, P. Fernandez-funez, S. Acevedo, Y. Lam, M. Kaytor et al., Interaction of Akt-Phosphorylated Ataxin-1 with 14-3-3 Mediates Neurodegeneration in Spinocerebellar Ataxia Type 1, Cell, vol.113, issue.4, pp.457-468, 2003.
DOI : 10.1016/S0092-8674(03)00349-0

A. Chêne, D. Donati, and A. Guerreiro-cacais, A Molecular Link between Malaria and Epstein???Barr Virus Reactivation, PLoS Pathogens, vol.3, issue.6, p.80, 2007.
DOI : 1475-2875(2004)003[0050:OEOPFE]2.0.CO;2

K. Choi, S. Lee, and S. Kwak, S05-02. Regulation of gene imprinting in arabidopsis, Mechanisms of Development, vol.126, pp.6-7629, 2005.
DOI : 10.1016/j.mod.2009.06.955

T. Choudhuri, S. Verma, K. Lan, M. Murakami, and E. Robertson, The ATM/ATR Signaling Effector Chk2 Is Targeted by Epstein-Barr Virus Nuclear Antigen 3C To Release the G2/M Cell Cycle Block, Journal of Virology, vol.81, issue.12, pp.816718-816748, 2007.
DOI : 10.1128/JVI.00053-07

K. Clark, A. Oelke, M. Johnson, K. Eilert, P. Simpson et al., CD81 Associates with 14-3-3 in a Redox-regulated Palmitoylation-dependent Manner, Journal of Biological Chemistry, vol.279, issue.19, pp.27919401-27919407, 2007.
DOI : 10.1074/jbc.M312626200

A. K. Datta, B. M. Colby, J. E. Shaw, and J. S. Pagano, Acyclovir inhibition of Epstein-Barr virus replication., Proceedings of the National Academy of Sciences, vol.77, issue.9, pp.775163-5166, 1980.
DOI : 10.1073/pnas.77.9.5163

H. Delecluse, R. Feederle, O. Sullivan, B. Taniere, and P. , Epstein Barr virus-associated tumours: an update for the attention of the working pathologist, Journal of Clinical Pathology, vol.60, issue.12, pp.601358-64, 2007.
DOI : 10.1136/jcp.2006.044586

R. Dolcetti and M. Boiocchi, Epstein-Barr virus in the pathogenesis of Hodgkin's disease, Biomedicine & Pharmacotherapy, vol.52, issue.1, pp.13-25, 1998.
DOI : 10.1016/S0753-3322(97)86237-3

M. Dougherty and D. Morrisson, Unlocking the code of 14-3-3, Journal of Cell Science, vol.117, issue.10, p.18751884, 2004.
DOI : 10.1242/jcs.01171

M. Epstein, G. Henlé, B. Achong, and Y. Barr, MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA, Journal of Experimental Medicine, vol.121, issue.5, pp.761-70, 1965.
DOI : 10.1084/jem.121.5.761

S. Fafi-kremer, P. Morand, and J. P. Brion, Long???Term Shedding of Infectious Epstein???Barr Virus after Infectious Mononucleosis, The Journal of Infectious Diseases, vol.191, issue.6, pp.191-985, 2005.
DOI : 10.1086/428097

H. Fahmi, C. Cochet, Z. Hmama, P. Opolon, and I. Joab, Transforming Growth Factor Beta 1 Stimulates Expression of the Epstein-Barr Virus BZLF1 Immediate-Early Gene Product ZEBRA by an Indirect Mechanism Which Requires the MAPK Kinase Pathway, Journal of Virology, vol.74, issue.13, pp.745810-5818, 2000.
DOI : 10.1128/JVI.74.13.5810-5818.2000

W. H. Feng, G. Hong, and H. Delecluse, Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas, Journal of Virology, vol.78, issue.4, pp.1893-1902, 2004.
DOI : 10.1128/JVI.78.4.1893-1902.2004

W. H. Feng, B. Israel, N. Raab-traub, P. Busson, and S. C. Kenney, Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors, Cancer Res, issue.6, pp.621920-1926, 2002.

W. H. Feng, E. Westphal, A. Mauser, N. Raab-traub, M. L. Gulley et al., Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive Tumors, Journal of Virology, vol.76, issue.21, pp.7610951-10959, 2002.
DOI : 10.1128/JVI.76.21.10951-10959.2002

E. Forte, M. Luftig, J. Fiori, and T. Camilli, The role of microRNAs in Epstein-Barr virus latency and lytic reactivation PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells, Microbes Infect Int J Med Sci, vol.6, issue.2, pp.93-101, 2009.

P. Gerber, J. Whang-peng, and J. Monroe, TRANSFORMATION AND CHROMOSOME CHANGES INDUCED BY EPSTEIN-BARR VIRUS IN NORMAL HUMAN LEUKOCYTE CULTURES, Proceedings of the National Academy of Sciences, vol.63, issue.3, pp.740-747, 1969.
DOI : 10.1073/pnas.63.3.740

E. Gershburg and J. Pagano, Epstein-Barr virus infections: prospects for treatment, Journal of Antimicrobial Chemotherapy, vol.56, issue.2, pp.277-81, 2005.
DOI : 10.1093/jac/dki240

B. A. Glaunsinger, S. S. Lee, M. Thomas, L. Banks, and R. Javier, Interactions of the PDZprotein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins, Oncogene, issue.46, pp.195270-5280, 2000.

H. Gruffat, J. Lupo, P. Morand, V. Boyer, and E. Manet, The Nuclear and Adherent Junction Complex Component Protein Ubinuclein Negatively Regulates the Productive Cycle of Epstein-Barr Virus in Epithelial Cells, Journal of Virology, vol.85, issue.2, pp.784-94, 2011.
DOI : 10.1128/JVI.01397-10

V. Hadinoto, M. Shapiro, C. C. Sun, and D. A. Thorley-lawson, The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output, PLoS Pathogens, vol.82, issue.7, p.1000496, 2009.
DOI : 10.1371/journal.ppat.1000496.s008

H. Hermeking, The 14-3-3 cancer connection, Nature Reviews Cancer, vol.3, issue.12, pp.931-943, 2003.
DOI : 10.1038/nrc1230

A. D. Hislop, G. S. Taylor, D. Sauce, and A. B. Rickinson, Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus, Annual Review of Immunology, vol.25, issue.1, pp.587-617, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141553

M. Ikeda, . Hikita, and . Asaki, Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia, Human Molecular Genetics, vol.17, issue.20, pp.173212-3222, 2008.
DOI : 10.1093/hmg/ddn217

B. F. Israel and C. K. Shannon, EBV lytic infection, Epstein Barr Virus, pp.571-601, 2005.

W. Jui-sheng, C. Wai-mui, and T. Yau-sheng, Ligand-activated peroxysome proliferatoractivated receptor-? protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3? upregulation, Circulation, issue.8, pp.1191124-1134, 2009.

G. Kang, S. Lee, W. Kim, H. Lee, J. Kim et al., Epstein-Barr Virus-Positive Gastric Carcinoma Demonstrates Frequent Aberrant Methylation of Multiple Genes and Constitutes CpG Island Methylator Phenotype-Positive Gastric Carcinoma, The American Journal of Pathology, vol.160, issue.3, pp.787-94, 2002.
DOI : 10.1016/S0002-9440(10)64901-2

J. Kawedia, M. Jiang, A. Kulkarni, H. Waechter, K. Matlin et al., The Protein Kinase A Pathway Contributes to Hg2+-Induced Alterations in Phosphorylation and Subcellular Distribution of Occludin Associated with Increased Tight Junction Permeability of Salivary Epithelial Cell Monolayers, Journal of Pharmacology and Experimental Therapeutics, vol.326, issue.3, pp.829-866, 2008.
DOI : 10.1124/jpet.107.135798

S. C. Kenney, E. Holley-guthrie, and E. B. Quinlivan, The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells., Molecular and Cellular Biology, vol.12, issue.1, pp.136-146, 1992.
DOI : 10.1128/MCB.12.1.136

J. Kenney, M. Guinness, T. Curiel, and L. J. , Antisense to the epstein-barr virus (EBV)encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells, Blood, issue.5, pp.921721-921728, 1998.

T. Kino, A. Gragerov, and A. Valentin, Vpr protein of HIV type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C : implication for cell cycle arrest, J Virol, issue.5, pp.792780-87, 2005.

S. Larrat, P. Morand, and A. Bas, Inhibition of Epstein-Barr virus replication by small interfering RNA targeting the Epstein-Barr virus protease gene, Antivir Ther, vol.14, issue.5, pp.655-62, 2009.

S. Lee, S. Park, C. Joe, and Y. Kim, Interaction of HCV core protein with 14-3-3?? protein releases Bax to activate apoptosis, Biochemical and Biophysical Research Communications, vol.352, issue.3, pp.756-62, 2007.
DOI : 10.1016/j.bbrc.2006.11.098

J. Li, M. Chia, W. Shi, D. Ngo, C. Strathdee et al., Tumor-targeted gene therapy for nasopharyngeal carcinoma, Cancer Res, vol.62, issue.1, pp.171-179, 2002.

J. Li, W. Shi, and M. Chia, Efficacy of targeted FasL in nasopharyngeal carcinoma, Molecular Therapy, vol.8, issue.6, pp.964-73, 2003.
DOI : 10.1016/j.ymthe.2003.08.018

Q. Li, M. Spriggs, S. Kovats, S. Turk, M. Comeau et al., Epstein- Barr virus uses HLA class II as a cofactor for infection of B lymphocytes, J Virol, issue.6, pp.714657-62, 1997.

J. Liou, D. Ghelani, S. Yeh, and K. Wu, Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon, Cancer Res, issue.7, pp.673185-91, 2007.

J. Liou, S. Lee, D. Ghelani, N. Matijevic-aleksic, and K. Wu, Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation, Arterioscler Thromb Vasc Biol, issue.7, pp.261481-261488, 2006.

D. Maas, C. Maret, L. Schaade, S. Scheithauer, K. Ritter et al., Reactivation of the Epstein???Barr virus from viral latency by an S-adenosylhomocysteine hydrolase/14-3-3 ??/PLA2-dependent pathway, Medical Microbiology and Immunology, vol.223, issue.4, pp.217-240, 2006.
DOI : 10.1007/s00430-006-0022-1

J. B. Mannick, K. Asano, K. Izumi, E. Kieff, and J. S. Stamler, Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation, Cell, vol.79, issue.7, pp.1137-1146, 1994.
DOI : 10.1016/0092-8674(94)90005-1

A. Muslin, J. Tanner, P. M. Allen, and A. Shaw, Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine, Cell, vol.84, issue.6, pp.889-897, 1996.
DOI : 10.1016/S0092-8674(00)81067-3

S. Nakagawa and J. M. Huibregtse, Human scribble (Vartul) is targeted for ubiquitinmediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitinprotein ligase, Mol Cell Biol, issue.21, pp.208244-8253, 2000.

S. Nakamuta, H. Endo, Y. Higashi, A. Kousaka, H. Yamada et al., Human immunodeficiency virus type 1 gp120???mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells, Journal of Neurovirology, vol.14, issue.3, pp.186-95, 2008.
DOI : 10.1080/13550280801993630

T. Obsil, R. Ghirlando, D. Klein, S. Ganguly, and F. Dyda, Crystal Structure of the 14-3-3??:Serotonin N-Acetyltransferase Complex, Cell, vol.105, issue.2, pp.257-67, 2001.
DOI : 10.1016/S0092-8674(01)00316-6

Y. Okamoto and S. Shikano, Phosphorylation-dependent C-terminal Binding of 14-3-3 Proteins Promotes Cell Surface Expression of HIV Co-receptor GPR15, Journal of Biological Chemistry, vol.286, issue.9, pp.7171-81, 2011.
DOI : 10.1074/jbc.M110.199695

C. Paludan, K. Bickham, and S. Nikiforow, Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt's Lymphoma Cells, The Journal of Immunology, vol.169, issue.3, pp.1593-603, 2002.
DOI : 10.4049/jimmunol.169.3.1593

C. Petosa, P. Morand, F. Baudin, M. Moulin, J. B. Artero et al., Structural Basis of Lytic Cycle Activation by the Epstein-Barr Virus ZEBRA Protein, Molecular Cell, vol.21, issue.4, pp.565-572, 2006.
DOI : 10.1016/j.molcel.2006.01.006

T. Petrocelli and J. Slingerland, UVB induced cell cycle checkpoints in an early stage human melanoma line, WM35, Oncogene, vol.19, issue.39, pp.4480-90, 2000.
DOI : 10.1038/sj.onc.1203808

S. Pfeffer, M. Zavolan, and F. Grässer, Identification of Virus-Encoded MicroRNAs, Science, vol.304, issue.5671, pp.304734-304740, 2004.
DOI : 10.1126/science.1096781

D. Portal, A. Rosendorff, and E. Kieff, Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4, Proceedings of the National Academy of Sciences, vol.103, issue.51, pp.19278-83, 2006.
DOI : 10.1073/pnas.0609320103

S. Rajan, R. Preisig-müller, and E. Wischmeyer, Interaction with 14-3-3 proteins promotes functional expression of the potassium channels TASK-1 and TASK-3, The Journal of Physiology, vol.276, issue.1, pp.13-26, 2002.
DOI : 10.1113/jphysiol.2002.027052

L. Resnick, J. Herbst, D. Ablashi, S. Atherton, B. Frank et al., Regression of Oral Hairy Leukoplakia After Orally Administered Acyclovir Therapy, JAMA: The Journal of the American Medical Association, vol.259, issue.3, pp.384-392, 1988.
DOI : 10.1001/jama.1988.03720030044031

A. B. Rickinson, E. D. Kieff, P. M. Howley, B. D. Griffin, R. A. Lamb et al., Epstein???Barr virus, Fields Virology. Lippincott Williams et Wilkins, pp.2655-2700, 2007.
DOI : 10.1016/S0168-1702(01)00436-1

URL : https://hal.archives-ouvertes.fr/inserm-00508046

C. Rooney, C. Smith, and C. Ng, Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation, The Lancet, vol.345, issue.8941, pp.3459-3472, 1995.
DOI : 10.1016/S0140-6736(95)91150-2

R. Rothe, L. Liguori, A. Villegas-mendez, B. Marques, D. Grunwald et al., Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA transactivator, J Biol Chem, issue.26, pp.28520224-28520257, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00763440

S. Roychowdhury, R. Peng, and R. Baiocchi, Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma, Cancer Res, vol.63, issue.5, pp.965-71, 2003.

R. Russo, F. Zito, C. Costa, R. Bonaventura, and V. Matranga, Transcriptional increase and misexpression of 14-3-3 epsilon in sea urchin embryos exposed to UV-B, Cell Stress and Chaperones, vol.165, issue.4, pp.15993-1001, 2010.
DOI : 10.1007/s12192-010-0210-1

H. Sakiyama, R. M. Wynn, and W. R. Lee, Regulation of nuclear import/export of carbohydrate response element-binding protein (ChREBP), J Biol Chem, issue.36, pp.28324899-24908, 2008.

H. Seimiya, H. Sawada, Y. Muramatsu, M. Shimizu, K. Ohko et al., Involvement of 14-3-3 proteins in nuclear localization of telomerase, The EMBO Journal, vol.19, issue.11, pp.192652-61, 2000.
DOI : 10.1093/emboj/19.11.2652

C. D. Shannon-lowe, B. Neuhierl, G. Baldwin, A. B. Rickinson, and H. J. Delecluse, Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells, Proceedings of the National Academy of Sciences, vol.103, issue.18, pp.7065-7070, 2006.
DOI : 10.1073/pnas.0510512103

A. Sinclair, bZIP proteins of human gammaherpesviruses, Journal of General Virology, vol.84, issue.8, pp.1941-1949, 2003.
DOI : 10.1099/vir.0.19112-0

N. Sista, C. Barry, K. Sampson, and J. Pagano, Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RAR alpha and RXR alpha, Nucleic Acids Res, issue.10, pp.231729-231765, 1995.

S. H. Speck, T. Chatila, and E. Flemington, Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene, Trends in Microbiology, vol.5, issue.10, pp.399-405, 1997.
DOI : 10.1016/S0966-842X(97)01129-3

M. Surjit, R. Kumar, R. Mishra, M. Reddy, V. Chow et al., The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein Is Phosphorylated and Localizes in the Cytoplasm by 14-3-3-Mediated Translocation, Journal of Virology, vol.79, issue.17, pp.7911476-11486, 2005.
DOI : 10.1128/JVI.79.17.11476-11486.2005

G. Szakonyi, M. G. Klein, and J. P. Hannan, Structure of the Epstein-Barr virus major envelope glycoprotein, Nature Structural & Molecular Biology, vol.73, issue.11, pp.13996-1001, 2006.
DOI : 10.1107/S0907444998003254

G. Taylor, T. Haigh, N. Gudgeon, R. Phelps, S. Lee et al., Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4+- and CD8+-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-Positive Nasopharyngeal Carcinoma, Journal of Virology, vol.78, issue.2, pp.768-78, 2004.
DOI : 10.1128/JVI.78.2.768-778.2004

D. A. Thorley-lawson, EBV persistence and latent infection in vivo, Epstein Barr Virus, pp.309-357, 2005.

D. Torre and R. Tambini, Acyclovir for treatment of infectious mononucleosis: a metaanalysis, Scand J Infect Dis, issue.66, pp.31543-547, 1999.

K. Toyo-oka, A. Shionoya, and M. J. Gambello, 14-3-3?? is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller???Dieker syndrome, Nature Genetics, vol.34, issue.3, pp.274-285, 2003.
DOI : 10.1038/ng1169

H. Tran, J. Nourse, S. Hall, M. Green, L. Griffiths et al., Immunodeficiency-associated lymphomas, Blood Reviews, vol.22, issue.5, pp.261-81, 2008.
DOI : 10.1016/j.blre.2008.03.009

G. Tzivion, Z. Luo, and J. Avruch, A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity, Nature, issue.6688, pp.39488-92, 1998.

C. Van-der-horst, J. Joncas, and G. Ahronheim, Lack of Effect of Peroral Acyclovir for the Treatment of Acute Infectious Mononucleosis, Journal of Infectious Diseases, vol.164, issue.4, pp.788-92, 1991.
DOI : 10.1093/infdis/164.4.788

H. Wagner, U. Sili, and B. Gahn, Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15, Cytotherapy, vol.5, issue.3, pp.231-271, 2003.
DOI : 10.1080/14653240310001262

H. Wakabayashi, M. Yano, N. Tachikawa, S. Oka, M. Maeda et al., Increased concentrations of 14-3-3??, ?? and ?? isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction, Clinica Chimica Acta, vol.312, issue.1-2, pp.97-105, 2001.
DOI : 10.1016/S0009-8981(01)00595-2

X. Wang, W. J. Kenyon, Q. Li, J. Mullberg, and L. M. Hutt-fletcher, Epstein-Barr Virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells, J virol, issue.7, pp.725552-725560, 1988.

K. Wu and J. Liou, Cyclooxygenase Inhibitors Induce Colon Cancer Cell Apoptosis Via PPAR?? ??? 14-3-3?? Pathway, Methods Mol Biol, vol.512, pp.295-307, 2009.
DOI : 10.1007/978-1-60327-530-9_16

J. Wu, W. Cheung, and Y. Tsai, Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation, Circulation, issue.8, pp.1191124-1191158, 2009.
DOI : 10.1161/circulationaha.108.812537

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144045

J. Xu, Dopamine-dependent neurotoxicity of ??-synuclein: A mechanism for selective neurodegeneration in Parkinson disease, Nature Medicine, vol.8, issue.6, pp.600-606, 2002.
DOI : 10.1038/nm0602-600

T. Yacoubian, S. Slone, A. Harrington, S. Hamamichi, J. Schieltz et al., Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease, Cell Death and Disease, vol.313, issue.1, p.2, 2010.
DOI : 10.1038/cddis.2009.4

M. B. Yaffe, K. Rittinger, and S. Volinia, The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity, Cell, vol.91, issue.7, pp.91961-71, 1997.
DOI : 10.1016/S0092-8674(00)80487-0

M. B. Yaffe, How do 14-3-3 proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis, FEBS Letters, vol.14, issue.1, pp.53-57, 2002.
DOI : 10.1016/S0014-5793(01)03288-4

M. Yajima, T. Kanda, and K. Takada, Critical Role of Epstein-Barr Virus (EBV)-Encoded RNA in Efficient EBV-Induced B-Lymphocyte Growth Transformation, Journal of Virology, vol.79, issue.7, pp.794298-307, 2005.
DOI : 10.1128/JVI.79.7.4298-4307.2005

M. Yano, S. Nakamuta, M. Shiota, H. Endo, and H. Kido, Gatekeeper role of 14-3-3?? protein in HIV-1 gp120-mediated apoptosis of human endothelial cells by inactivation of Bad, AIDS, vol.21, issue.8, pp.911-931, 2007.
DOI : 10.1097/QAD.0b013e32810539f3

L. S. Young and P. Murray, Epstein???Barr virus and oncogenesis: from latent genes to tumours, Oncogene, vol.22, issue.33, pp.225108-225129, 2003.
DOI : 10.1038/sj.onc.1206556

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=

L. S. Young and A. B. Rickinson, Epstein???Barr virus: 40 years on, Nature Reviews Cancer, vol.10, issue.10, pp.757-768, 2004.
DOI : 10.1038/sj.onc.1206556

M. Zannis-hadjopoulos, W. Yahyaoui, and M. Callejo, 14-3-3 Cruciform-binding proteins as regulators of eukaryotic DNA replication, Trends in Biochemical Sciences, vol.33, issue.1, pp.44-50, 2007.
DOI : 10.1016/j.tibs.2007.09.012

D. Zerby, C. J. Chen, E. Poon, D. Lee, R. Shiekhattar et al., The Amino-Terminal C/H1 Domain of CREB Binding Protein Mediates Zta Transcriptional Activation of Latent Epstein-Barr Virus, Molecular and Cellular Biology, vol.19, issue.3, pp.1617-1626, 1999.
DOI : 10.1128/MCB.19.3.1617

S. Zuo, Y. Xue, S. Tang, J. Yao, R. Du et al., 14-3-3 Epsilon Dynamically Interacts with Key Components of Mitogen-Activated Protein Kinase Signal Module for Selective Modulation of the TNF-??-Induced Time Course-Dependent NF-??B Activity, Journal of Proteome Research, vol.9, issue.7, pp.3465-78, 2010.
DOI : 10.1021/pr9011377